home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

Optimizing Dosing for the Safe and Effective Use of Drugs in Patients with Renal Impairment

 
  April 03, 2011  
     
 
Omni Shoreham Hotel , Washington, DC, USA
Sep 19 2011 7:00AM - Sep 20 2011 4:00PM


Explore Ways to Facilitate Drug Development and Optimize Dosing in Renal Impairment.

Patients with renal impairment are at increased risk for developing drugrelated
adverse events. In these patients drug dosage needs to be closely monitored and adjusted to refl ect altered pharmacokinetics (PK) and pharmacodynamics (PD) parameters. This conference will provide a forum for the discussion of the following concepts:
• What to consider when designing, conducting, and analyzing dedicated renal impairment studies
• How to estimate renal function
• How to label a drug to provide clinically relevant information on the effects of reduced renal function on the drug’s PK/PD properties
• How to integrate and interpret data from a specific drug development program to assess the effects of renal impairment on drug safety
and efficacy
• How to determine the magnitude of dose adjustment required as renal function declines
• How to move from clinical trial data to real world practice when dosing special populations (i.e. morbidly obese)

HIGHLIGHTS
• Breakout sessions for study design and analysis
• Expert panel discussions


Event Code:
11024
 
 
Organized by: Marjorie Davis
Invited Speakers: See website for speaker information
 
Deadline for Abstracts: Call contact
 
Registration:
Contact Marjorie Davis, Phone +1.215.442.6176 begin_of_the_skype_highlighting            +1.215.442.6176      end_of_the_skype_highlighting
Fax +1.215.442.6199, email
Marjorie.Davis@diahome.org
E-mail: marjorie.davis@diahome.org
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.